PRGO (Perrigo Company plc) Stock Financials & Earnings | Market Cap Arena

PRGO (Perrigo Company plc) Stock Financials & Earnings | Market Cap Arena

PRGOPerrigo Company plc

Mkt Cap$1B

Healthcare·Drug Manufacturers - Specialty & Generic·🇮🇪 Ireland·NYSE

Revenue (TTM)$4.3B

Net Income (TTM)-$1.4B

EPS (TTM)-$10.29

Free Cash Flow (TTM)$145M

Gross Margin35.1%

Op. Margin5.9%

Net Margin-33.5%

FCF Margin3.4%

P/S Ratio (TTM)0.3x

P/E Ratio (TTM)—

YoY Rev Growth-2.8%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$1.2B	$414M	$49M
Q2 23	$1.2B	$428M	$57M
Q3 23	$1.1B	$411M	$62M
Q4 23	$1.2B	$427M	-$16M
Q1 24	$1.1B	$358M	-$55M
Q2 24	$1.1B	$395M	-$27M
Q3 24	$1.1B	$404M	$80M
Q4 24	$1.1B	$386M	$114M
Q1 25	$1.0B	$392M	$47M
Q2 25	$1.1B	$363M	$45M
Q3 25	$1.0B	$377M	$73M
Q4 25	$1.1B	$362M	$85M

Valuation

Quarter	P/S	P/E
Q1 23	0.3x	—
Q2 23	0.3x	—
Q3 23	0.3x	—
Q4 23	0.3x	—
Q1 24	0.3x	—
Q2 24	0.3x	—
Q3 24	0.3x	—
Q4 24	0.3x	—
Q1 25	0.3x	—
Q2 25	0.3x	—
Q3 25	0.3x	—
Q4 25	0.3x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	$19M	-$4M
Q2 23	$53M	$33M
Q3 23	$125M	$93M
Q4 23	$209M	$182M
Q1 24	-$1M	-$27M
Q2 24	$10M	-$19M
Q3 24	$42M	$15M
Q4 24	$313M	$275M
Q1 25	-$65M	-$90M
Q2 25	$76M	$57M
Q3 25	$52M	$30M
Q4 25	$175M	$149M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$23M
Q2 23	$20M
Q3 23	$32M
Q4 23	$27M
Q1 24	$25M
Q2 24	$28M
Q3 24	$27M
Q4 24	$38M
Q1 25	$26M
Q2 25	$19M
Q3 25	$22M
Q4 25	$27M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+10.0%	+7.6%
Q2 23	+6.4%	+0.7%
Q3 23	+2.1%	-0.5%
Q4 23	+0.1%	+4.3%
Q1 24	-8.4%	+0.4%
Q2 24	-10.7%	-3.9%
Q3 24	-3.2%	-5.1%
Q4 24	-1.6%	-12.7%
Q1 25	-3.5%	-12.3%
Q2 25	-0.9%	-7.4%
Q3 25	-4.1%	-3.6%
Q4 25	-2.5%	+0.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$25M	2.1%
Q2 23	$19M	1.6%
Q3 23	$15M	1.3%
Q4 23	$11M	0.9%
Q1 24	$16M	1.4%
Q2 24	$23M	2.2%
Q3 24	$6M	0.5%
Q4 24	$20M	1.7%
Q1 25	$0	0.0%
Q2 25	$0	0.0%
Q3 25	$0	0.0%
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 23	$31M	$135M	$197M
Q2 23	$32M	$133M	$200M
Q3 23	$30M	$126M	$178M
Q4 23	$30M	$129M	$178M
Q1 24	$29M	$130M	$175M
Q2 24	$29M	$126M	$175M
Q3 24	$26M	$117M	$155M
Q4 24	$28M	$95M	$140M
Q1 25	$27M	$112M	$169M
Q2 25	$22M	$113M	$160M
Q3 25	$25M	$94M	$127M
Q4 25	$22M	—	$70M

Revenue Segments

Quarter	Consumer Self-Care Americas	Consumer Self-Care International
Q1 23	$764M	$418M
Q2 23	$751M	$442M
Q3 23	$704M	$420M
Q4 23	$744M	$413M
Q1 24	$644M	$438M
Q2 24	$634M	$431M
Q3 24	$671M	$416M
Q4 24	$744M	$394M
Q1 25	$621M	$423M
Q2 25	$622M	$434M
Q3 25	$646M	$398M
Q4 25	$697M	$413M

Revenue by Geography

Quarter	Europe	Ireland	Other Geographical Areas	United States
Q1 23	$407M	$7M	$24M	$750M
Q2 23	$426M	$12M	$32M	$736M
Q3 23	$400M	$12M	$34M	$690M
Q4 23	$390M	$10M	$27M	$741M
Q1 24	$420M	$4M	$30M	$632M
Q2 24	$408M	$11M	$29M	$628M
Q3 24	$397M	$11M	$33M	$657M
Q4 24	$379M	$13M	$27M	$732M
Q1 25	$412M	$11M	$22M	$609M
Q2 25	$422M	$10M	$24M	$611M
Q3 25	$384M	$9M	$24M	$635M
Q4 25	$398M	$13M	$27M	$685M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$553M	$0	$553M
Q2 23	$555M	$0	$555M
Q3 23	$598M	$0	$598M
Q4 23	$751M	$0	$751M
Q1 24	$652M	$0	$652M
Q2 24	$538M	$0	$538M
Q3 24	$1.5B	$0	$1.5B
Q4 24	$559M	$0	$559M
Q1 25	$410M	$0	$410M
Q2 25	$454M	$0	$454M
Q3 25	$432M	$0	$432M
Q4 25	$532M	$0	$532M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	135M	+0.1%
Q2 23	137M	+1.3%
Q3 23	137M	+0.2%
Q4 23	136M	-1.0%
Q1 24	138M	+1.5%
Q2 24	137M	-0.4%
Q3 24	138M	+0.3%
Q4 24	138M	+0.1%
Q1 25	138M	+0.1%
Q2 25	138M	+0.4%
Q3 25	139M	+0.5%
Q4 25	139M	-0.3%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$397K	10K
FY 15	$341K	14K
FY 16	$413K	13K
FY 17	$476K	10K
FY 18	$446K	11K
FY 19	$346K	11K
FY 20	$355K	12K
FY 21	$418K	10K
FY 22	$500K	9K
FY 23	$509K	9K
FY 24	$522K	8K
FY 25	$525K	8K